Journals / Turkish Journal of Pediatrics / 2019 / Cilt: 61 - Sayı: 5

Impacts of phototherapy on DNA damage and total oxidant/ antioxidant status in jaundiced newborns

Pages
697–703
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However,the TAC decreased significantly in both groups after phototherapy (p < 0.01).These findings suggest that conventional and intensive phototherapies do notaffect DNA damage and oxidative stress, supporting the safety of its use as thepreferred treatment for jaundiced newborns.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Jaundice is common in newborn babies, and pathologic hyperbilirubinemia isfrequently treated with phototherapy.
📊
Key Findings & Data:The study groupincluded 40 newborns (gestation age ≥ 37 weeks) on days 2–8 after birth.Newborns were divided into two groups on the basis of need for phototherapy:20 newborns were exposed to conventional phototherapy (Group I); and 20infants were exposed to intensive phototherapy (Group II).
💡
Conclusion & Impact:However,the TAC decreased significantly in both groups after phototherapy (p < 0.01).These findings suggest that conventional and intensive phototherapies do notaffect DNA damage and oxidative stress, supporting the safety of its use as thepreferred treatment for jaundiced newborns.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Jaundice is common in newborn babies, and pathologic hyperbilirubinemia isfrequently treated with phototherapy. Although it is considered to be safe, theside effects of phototherapy in newborns are still a matter of debate. In thisstudy, the impacts of two types of phototherapy, conventional fluorescenceand intensive light-emitting diodes (LED), on DNA damage and total oxidant/antioxidant status in jaundiced newborns were assessed. The study groupincluded 40 newborns (gestation age ≥ 37 weeks) on days 2–8 after birth.Newborns were divided into two groups on the basis of need for phototherapy:20 newborns were exposed to conventional phototherapy (Group I); and 20infants were exposed to intensive phototherapy (Group II). Blood sampleswere taken from all infants at admission and after phototherapy to determineplasma 8-hydroxy-2-deoxy-guanosine (8-OH-dG; a marker of DNA damage),total oxidant status (TOS), and total antioxidant capacity (TAC). The oxidativestress index (OSI) was also calculated. Demographic information was recorded,and DNA damage, TOS, and TAC were compared. There were no differences indemographic information between the two groups. There were no significantdifferences in DNA damage, TOS, TAC, and OSI between Groups I and II beforephototherapy (p > 0.05) and no significant differences in DNA damage, TOS,TAC, and OSI between the two groups after phototherapy (p > 0.05). However,the TAC decreased significantly in both groups after phototherapy (p < 0.01).These findings suggest that conventional and intensive phototherapies do notaffect DNA damage and oxidative stress, supporting the safety of its use as thepreferred treatment for jaundiced newborns.

🔖

Cite This Article

Bulut, Ö., Dürüyen, S. (2022). Impacts of phototherapy on DNA damage and total oxidant/ antioxidant status in jaundiced newborns. Turkish Journal of Pediatrics, Cilt: 61 - Sayı: 5, 697–703. https://ajindex.com/articles/613110

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Maisels MJ, Gifford K, Antle CE, Leib GR. Jaundice in the healthy newborn infant: a new approach to an old problem. Pediatrics 1988; 81: 505-511
  2. Kaplan M, Hammerman C. Understanding severe hyperbilirubinemia and preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin. Clin Chim Acta 2005; 356: 9-21
  3. Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med 2008; 358: 920-928
  4. Lightner DA, McDonagh AF. Molecular mechanisms of phototherapy for neonatal jaundice. Acc Chem Res 1984; 17: 417-424
  5. Porter ML, Dennis BL. Hyperbilirubinemia in the term newborn. Am Fam Physician 2002; 65: 599-606
  6. Vreman HJ, Wong RJ, Stevenson DK. Phototherapy: current methods and future directions. Semin Perinatol 2004; 28: 326-333
  7. Dani C, Martelli E, Reali MF, Bertini G, Panin G, Rubaltelli F. Fiberoptic and conventional phototherapy effects on the skin of premature infants. J Pediatr 2001; 138: 438-440
  8. Maisels MJ. Phototherpy-tradiotional and nontradiotinal. J Perinatol 2001; 21(Suppl 1): S93-S97
  9. Gathwala G, Sharma S. Oxidative stress, phototherapy and the neonate. Indian J Pediatr 2000; 67: 805-808
  10. Aycicek A, Erel O. Total oxidant/antioxidant status in jaundiced newborns before and after phototherapy. J Pediatr (Rio J) 2007; 83: 319-322
  11. Tatli MM, Minnet C, Kocyigit A, Karadag A. Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates. Mutat Res 2008; 654: 93-95
  12. Kale Y, Aydemir O, Celik U, et al. Effects of phototherapy using different light sources on oxidant and antioxidant status of neonates with jaundice. Early Hum Dev 2013; 89: 957-960
  13. Yahia S, Shabaan AE, Gouida M, et al. Influence of hyperbilirubinemia and phototherapy on markers of genotoxicity and apoptosis in full-term infants. Eur J Pediatr 2015; 174: 459-464
  14. Ramy N, Ghany EA, Alsharany W, et al. Jaundice, phototherapy and DNA damage in full-term neonates J Perinatol 2016; 36: 132-136
  15. Allam A, Ravikiran SR, Baliga BS, Bhat K, Joseph N. Effect of conventional and LED phototherapy on the antioxidant-oxidant status in preterm neonates with jaundice. Indian Pediatr 2017; 54: 644-646
  16. Perrone S, Tataranno ML, Stazzoni G, Buonocore G. Biomarkers of oxidative stress in fetal and neonatal diseases. J Matern Fetal Neonatal Med 2012; 25: 2575-2578
  17. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestati